Director at enVVeno Medical (NASDAQ: NVNO) sells 140 shares under Rule 10b5-1 plan

Rhea-AI Filing Summary

enVVeno Medical Corp director Francis Duhay sold a small block of company stock in a pre-planned trade. On June 11, 2026, he completed an open-market sale of 140 shares of common stock at $10.305 per share. After this transaction, he directly holds 2,362 shares of enVVeno Medical Corp common stock. The sale was executed under a Rule 10b5-1 trading plan that he adopted in June 2025, indicating the trade was pre-scheduled rather than a discretionary decision based on recent developments.

Insider Trade Summary 10b5-1

Net Seller: 140 shares ($1,443)

Net Sell 1 txn

Insider Duhay Francis

Role Director

Sold 140 shs ($1K)

Type	Security	Shares	Price	Value
Sale	Common Stock	140	$10.305	$1K

Holdings After Transaction: Common Stock — 2,362 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 140 shares Sale price: $10.305 per share Shares held after: 2,362 shares

3 metrics

Shares sold 140 shares Open-market sale on June 11, 2026

Sale price $10.305 per share Price for 140 common shares sold

Shares held after 2,362 shares Direct ownership following the transaction

Key Terms

Rule 10b5-1 trading plan, open-market sale, Form 4, transaction code "S"

4 terms

Rule 10b5-1 trading plan regulatory

"This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code "S" regulatory

"transaction_code_description: "Sale in open market or private transaction""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 04:06 PM Accepted by SEC EDGAR 06/12/2026 - 04:05 PM Learn about SEC filing dates

FAQ

What insider transaction did enVVeno Medical Corp (NVNO) report for Francis Duhay?

enVVeno Medical Corp reported that director Francis Duhay sold 140 shares of common stock in an open-market transaction on June 11, 2026. The shares were sold at $10.305 per share under an existing Rule 10b5-1 trading plan.

How many enVVeno Medical Corp (NVNO) shares did Francis Duhay retain after the sale?

After the sale, director Francis Duhay directly holds 2,362 shares of enVVeno Medical Corp common stock. This filing shows his updated direct ownership position following the open-market sale of 140 shares executed on June 11, 2026.

At what price did Francis Duhay sell enVVeno Medical Corp (NVNO) shares?

Francis Duhay sold 140 shares of enVVeno Medical Corp common stock at an average price of $10.305 per share. The transaction was reported as an open-market sale and was made pursuant to a pre-established Rule 10b5-1 trading plan.

Was Francis Duhay’s enVVeno Medical Corp (NVNO) stock sale pre-planned?

Yes. The filing states the transaction was completed under a Rule 10b5-1 trading plan adopted by Francis Duhay in June 2025. Such plans are pre-arranged trading programs, indicating the timing of this 140-share sale was scheduled in advance.

What type of transaction did enVVeno Medical Corp (NVNO) disclose for Francis Duhay?

The company disclosed an open-market sale of common stock by director Francis Duhay. The Form 4 lists a transaction code “S,” describing a sale in the open market or a private transaction, covering 140 shares at $10.305 per share.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Duhay Francis

(Last) (First) (Middle)

C/O ENVVENO MEDICAL CORPORATION,

70 DOPPLER

(Street)

IRVINE CALIFORNIA 92618

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
enVVeno Medical Corp [ NVNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		S(1)		140	D	$10.305	2,362	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.

	/s/ Francis Duhay	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)